Artrya appoints Kate Hill as Non-Executive Director
We are delighted to have partnered with Artrya on the appointment of Kate Hill as their new Non-Executive Director
Artrya (ASX:AYA) is a medical technology company that applies artificial intelligence to improve the diagnosis of coronary disease. Artrya has developed deep learning algorithms that will streamline the delivery of medical care and has successfully combined the passion of the founders for disruptive technology and improved health outcomes.
Kate spent 20+ years as an Audit Partner at Deloitte before moving into non-executive roles, currently as Chair of Seeing Machines Ltd (LON:SEE) and a Director of Countplus Ltd (ASX:CUP). Kate is a Chartered Accountant with broad experience in the technology, biotech and medical devices sectors.
““Kate's experience at Board level with ASX listed companies, particularly in the technology, biotech and medical devices sectors will be invaluable as Artrya moves into its next phase of growth…'' ”– Bernie Ridgeway, Chair
For Artrya’s full announcement, please click here.
Many thanks to the Account Team: Jane Bridge, Vanessa Bathe, Spyridon Revithis and Gail Walsh.
